Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vyne Therapeutics Inc VYNE

Healthcare
VYNE Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing differentiated therapies for the treatment of immuno-inflammatory conditions. Its product candidate is VYN201, a locally administered pan-BET inhibitor designed as a soft drug to address diseases involving multiple, diverse inflammatory cell signaling pathways while providing low systemic exposure. Its... see more

Recent & Breaking News (NDAQ:VYNE)

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Menlo Therapeutics Inc. (MNLO)

GlobeNewswire October 22, 2018

Menlo Therapeutics Announces Results from a Phase 2 Clinical Trial of Serlopitant for the Treatment of Refractory Chronic Cough

GlobeNewswire October 8, 2018

Johnson Fistel Announces Investigations of PPDAI Group Inc., Menlo Therapeutics Inc., Eyenovia, Inc. and Dragon Victory International Limited; Investors with Losses Encouraged to Contact Firm

PR Newswire October 5, 2018

INVESTOR ALERT: Kaskela Law LLC Announces Investigation of Menlo Therapeutics Inc. on Behalf of Investors - MNLO

Accesswire September 25, 2018

Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating Possible Securities Fraud Violations by Certain Officers and Directors of Alnylam, Global Blood, and NiSource on Behalf of Stockholders and Encourages Investors to Contact the Firm

GlobeNewswire September 24, 2018

Menlo Therapeutics Begins European Prurigo Nodularis Phase 3 Trial and Presents Additional Data from PN Phase 2 Trial at EADV

GlobeNewswire September 17, 2018

Lifshitz & Miller LLP Announces Investigation of American Express Company, GDS Holdings Limited, Lannett Company, Inc., Mednax, Inc., Menlo Therapeutics Inc., Papa John's International, Inc., Tetraphase Pharmaceuticals, Inc. and Zion Oil & Gas, Inc.

PR Newswire September 12, 2018

Consolidated Research: 2018 Summary Expectations for SpartanNash, Encana, Hilltop, Pacira Pharmaceuticals, Menlo Therapeutics, and Rayonier Advanced Materials — Fundamental Analysis, Key Performance Indications

GlobeNewswire August 23, 2018

Scott+Scott Attorneys at Law LLP Reminds Investors of its Investigation into Menlo Therapeutics Inc. (MNLO)

Business Wire August 15, 2018

Kaskela Law LLC Announces Investigation of Menlo Therapeutics Inc. on Behalf of Shareholders - MNLO

Accesswire August 10, 2018

Investigation On Behalf Of Menlo Therapeutics Shareholders For Recovery Of Investment Losses

Canada NewsWire August 10, 2018

Bragar Eagel & Squire, P.C. is Investigating Menlo Therapeutics Inc. (MNLO) on Behalf of Stockholders and Encourages Investors to Contact the Firm

GlobeNewswire August 2, 2018

Kaskela Law LLC Announces Investigation of Menlo Therapeutics Inc. on Behalf of Investors - MNLO

Accesswire August 2, 2018

Menlo Therapeutics Reports Second Quarter 2018 Financial Results and Provides Business Update

GlobeNewswire August 1, 2018

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Helios and Matheson Analytics Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

Business Wire August 1, 2018

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of LogMeIn, Inc. (LOGM)

PR Newswire August 1, 2018

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Helios and Matheson Analytics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire July 31, 2018

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Helios and Matheson Analytics Inc.

Business Wire July 31, 2018

Scott+Scott Attorneys at Law LLP Reminds Investors of its Investigation into Menlo Therapeutics Inc. (MNLO)

Business Wire July 18, 2018

Scott+Scott Attorneys at Law LLP Announces Investigation into Menlo Therapeutics Inc. (MNLO)

PR Newswire June 19, 2018